A systematic review of omega-3 fatty acids and osteoporosis

British Journal of Nutrition

Volumn 107, Issue SUPPL. 2, 2012, Pages

  Orchard, Tonya S ^a   Pan, Xueliang ^a   Cheek, Fern ^a   Ing, Steven W ^b   Jackson, Rebecca D ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Aged; Bone density; Cognition; Elderly; Nutritional status; Omega 3 fatty acids; Systematic review

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; FISH OIL; ICOSANOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LINSEED OIL; OMEGA 3 FATTY ACID; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PLACEBO; PRIMROSE OIL; PROSTAGLANDIN E2;

BONE MINERAL; BONE TURNOVER; DIET SUPPLEMENTATION; DRUG EFFECT; FAT INTAKE; HIP FRACTURE; HUMAN; NONHUMAN; OSSIFICATION; OSTEOLYSIS; OSTEOPOROSIS; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESISTANCE TRAINING; REVIEW; RHEUMATOID ARTHRITIS; RISK REDUCTION; SYSTEMATIC REVIEW;

BONE AND BONES; BONE DENSITY; BONE RESORPTION; DIET; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FRACTURES, BONE; HUMANS; OSTEOGENESIS; OSTEOPOROSIS;

EID: 84861164614     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114512001638     Document Type: Review

References (57)

1. Dyerberg J, Bang HO, Stoffersen E, et al. (1978) Eicospentaenoic acid and prevention of thrombosis and atherosclerosis? The Lancet 312, 8081, 117-119. (Pubitemid 8373454)
2. Bang HO, Dyerberg J & Sinclair HM (1980) The composition of the Eskimo food in north western Greenland. Am J Clin Nutr 33, 12, 2657-2661. (Pubitemid 11172006)
3. Bang HO & Dyerberg J (1987) Fatty acid pattern and ischaemic heart disease. Lancet 1, 8533, 633. (Pubitemid 17024257)
4. Block RC, Harris WS, Reid KJ, et al. (2008) EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls. Atherosclerosis 197, 2, 821-828. (Pubitemid 351417881)
5. Marchioli R, Schweiger C, Tavazzi L, et al. (2001) Efficacy of n-3 polyunsaturated fatty acids after myocardial infarction: results of GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. Lipids Suppl. S1, 36, 19-26.
6. Das UN (2002) Estrogen, statins, and polyunsaturated fatty acids: similarities in their actions and benefits-is there a common link? Nutrition (Burbank, Los Angeles County, Calif.) 18, 2, 178-188. (Pubitemid 34158679)
7. Simopoulos AP (2002) Omega-3 Fatty Acids in Inflammation and Autoimmune Diseases. J Am Coll Nutr 21, 6, 495-505. (Pubitemid 36026261)
8. Dawczynski C, Schubert R, Hein G, et al. (2009) Long-term moderate intervention with n-3 long-chain PUFA-supplemented dairy products: effects on pathophysiological biomarkers in patients with rheumatoid arthritis. The British journal of nutrition 101, 10, 1517-1526.
9. Ding C, Parameswaran V, Udayan R, et al. (2008) Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study. J Clin Endocrinol Metab 93, 5, 1952-1958. (Pubitemid 351656543)
10. Cauley JA, Danielson ME, Boudreau RM, et al. (2007) Inflammatory markers and incident fracture risk in older men and women: the Health Aging and Body Composition Study. J Bone Miner Res 22, 7, 1088-1095. (Pubitemid 351339731)
11. Watkins BA, Lippman HE, Le Bouteiller L, et al. (2001) Bioactive fatty acids: role in bone biology and bone cell function. Progress in lipid research 1-2, 40, 125-148. (Pubitemid 32008652)
12. Zhang Y-H, Heulsmann A, Tondravi MM, et al. (2001) Tumor Necrosis Factor-alpha (TNF) Stimulates RANKL-induced Osteoclastogenesis via Coupling of TNF Type 1 Receptor and RANK Signaling Pathways. J Biol Chem 276, 1, 563-568. (Pubitemid 32050352)
13. Kruger MC, Coetzee M, Haag M, et al. (2010) Long-chain polyunsaturated fatty acids: selected mechanisms of action on bone. Progress in lipid research 49, 4, 438-449.
14. WHO (2004) WHO Scientific Group on the Assessment of Osteoporoosis at Primary Health Care Level [cited 2011 June 16, 2011]. Available from: http://www.who.int/chp/topics/Osteoporosis.pdf
15. Hofbauer LC & Schoppet M (2004) Clinical Implications of the Osteoprotegerin/RANKL/RANK System for Bone and Vascular Diseases. JAMA 292, 4, 490-495. (Pubitemid 38988958)
16. Boyce BF & Xing L (2007) Biology of RANK, RANKL, and osteoprotegerin. Arthritis research & therapy 9, Suppl. 1, S1.
17. Coetzee M, Haag M & Kruger MC (2007) Effects of arachidonic acid, docosahexaenoic acid, prostaglandin E(2) and parathyroid hormone on osteoprotegerin and RANKL secretion by MC3T3-E1 osteoblast-like cells. The Journal of nutritional biochemistry 18, 1, 54-63. (Pubitemid 44827720)
18. Hogstrom M, Nordstrom P & Nordstrom A (2007) n-3 Fatty acids are positively associated with peak bone mineral density and bone accrual in healthy men: the NO2 Study. Am J Clin Nutr 85, 3, 803-807. (Pubitemid 46393513)
19. Weiss LA, Barrett-Connor E & von Muhlen D (2005) Ratio of n-6 to n-3 fatty acids and bone mineral density in older adults: the Rancho Bernardo Study. Am J Clin Nutr 81, 4, 934-938. (Pubitemid 41725005)
20. Macdonald HM, New SA, Golden MHN, et al. (2004) Nutritional associations with bone loss during the menopausal transition: evidence of a beneficial effect of calcium, alcohol, and fruit and vegetable nutrients and of a detrimental effect of fatty acids. Am J Clin Nutr 79, 1, 155-165. (Pubitemid 41132077)
21. Trebble TM, Stroud MA, Wootton SA, et al. (2005) High-dose fish oil and antioxidants in Crohn's disease and the response of bone turnover: a randomised controlled trial. The British journal of nutrition 94, 2, 253-261. (Pubitemid 41357797)
22. Stipanuk MH, Biochemical and Physiological Aspects of Human Nutrition: W.B. Saunders Company.
23. Albertazzi P & Coupland K (2002) Polyunsaturated fatty acids. Is there a role in postmenopausal osteoporosis prevention? Maturitas 42, 1, 13-22. (Pubitemid 34521717)
24. Kris-Etherton PM, Taylor DS, Yu-Poth S, et al. (2000) Polyunsaturated fatty acids in the food chain in the United States. Am J Clin Nutr 71, Suppl. 1, 179S-188S. (Pubitemid 30046114)
25. Whelan J & Rust C (2006) Innovative dietary sources of n-3 fatty acids. Annual review of nutrition 26, 75-103.
26. Appleby P, Roddam A, Allen N, et al. (2007) Comparative fracture risk in vegetarians and nonvegetarians in EPIC-Oxford. Eur J Clin Nutr 61, 12, 1400-1406. (Pubitemid 350245914)
27. Martinez-Ramirez MJ, Palma S, Martinez-Gonzalez MA, et al. (2007) Dietary fat intake and the risk of osteoporotic fractures in the elderly. Eur J Clin Nutr 61, 9, 1114-1120. (Pubitemid 47386598)
28. Orchard TS, Cauley JA, Frank GC, et al. (2010) Fatty acid consumption and risk of fracture in the Women's Health Initiative. The American Journal of Clinical Nutrition 92, 6, 1452-1460.
29. Farina EK, Kiel DP, Roubenoff R, et al. (2011) Dietary Intakes of Arachidonic Acid and {alpha}-Linolenic Acid Are Associated with Reduced Risk of Hip Fracture in Older Adults. The Journal of nutrition 141, 6, 1146-1153.
30. Virtanen JK, Mozaffarian D, Cauley JA, et al. (2010) Fish consumption, bone mineral density, and risk of hip fracture among older adults: the cardiovascular health study. J Bone Miner Res 25, 9, 1972-1979.
31. Suzuki T, Yoshida H, Hashimoto T, et al. (1997) Case-control study of risk factors for hip fractures in the Japanese elderly by a Mediterranean Osteoporosis Study (MEDOS) questionnaire. Bone 21, 5, 461-467. (Pubitemid 27485316)
32. U.S. National Library of Medicine, National Institutes of Health (2011) OLDMEDLINE Data, http://www.nlm.nih.gov/databases/databases-oldmedline.html. Accessed 10/21/11
33. Balshem H, Helfand M, Schunemann HJ, et al. (2011) GRADE guidelines: 3. Rating the quality of evidence. Journal of clinical epidemiology 64, 4, 401-406.
34. Terracciano L, Brozek J, Compalati E, et al. (2010) GRADE system: new paradigm. Current opinion in allergy and clinical immunology 10, 4, 377-383.
35. Cohen J (1988) Statistical Power Analysis for the Behavioral Sciences, 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Assoc.
36. Rosnow RaRR (1996) Computing contrasts, effect sizes, and counternulls on other people's published data: general procedures for research consumers. Psych Meth 1, 331-340.
37. Hedges LaO I (1985) Statistical Methods for Meta-analys. New York, NY: Academic Press.
38. Martin-Bautista E, Muãoz-Torres M, Fonolla J, et al. (2010) Improvement of bone formation biomarkers after 1-year consumption with milk fortified with eicosapentaenoic acid, docosahexaenoic acid, oleic acid, and selected vitamins. Nutrition research (New York, NY) 30, 5, 320-326.
39. Griel AE, Kris-Etherton PM, Hilpert KF, et al. (2007) An increase in dietary n-3 fatty acids decreases a marker of bone resorption in humans. Nutr J 6, 2.
40. Kruger MC, Coetzer H, de Winter R, et al. (1998) Calcium, gamma-linolenic acid and eicosapentaenoic acid supplementation in senile osteoporosis. Aging (Milano) 10, 5, 385-394.
41. Appleton KM, Fraser WD, Rogers PJ, et al. (2011) Supplementation with a low-moderate dose of n-3 long-chain PUFA has no short-term effect on bone resorption in human adults. The British journal of nutrition 105, 8, 1145-1149.
42. Salari Sharif P, Asalforoush M & Ameri FThe effect of n-3 fatty acids on bone biomarkers in Iranian postmenopausal osteoporotic women: a randomized clinical trial. AGE 32, 2, 179-186.
43. Dodin S, Lemay A, Jacques H, et al. (2005) The Effects of Flaxseed Dietary Supplement on Lipid Profile. Bone Mineral Density, and Symptoms in Menopausal Women: A Randomized, Double-Blind, Wheat Germ Placebo-Controlled Clinical Trial. J Clin Endocrinol Metab 90, 3, 1390-1397. (Pubitemid 40463994)
44. Cornish SM & Chilibeck PD (2009) Alpha-linolenic acid supplementation and resistance training in older adults. Applied physiology, nutrition, and metabolism ¼ Physiologie appliquee, nutrition et metabolisme 34, 1, 49-59.
45. Bassey EJ, Littlewood JJ, Rothwell MC, et al. (2000) Lack of effect of supplementation with essential fatty acids on bone mineral density in healthy pre-and postmenopausal women: two randomized controlled trials of Efacal v. calcium alone. The British journal of nutrition 83, 6, 629-635. (Pubitemid 30392103)
46. Kolahi S, Ghorbanihaghjo A, Alizadeh S, et al. (2010) Fish oil supplementation decreases serum soluble receptor activator of nuclear factor-kappa B ligand/osteoprotegerin ratio in female patients with rheumatoid arthritis. Clinical Biochemistry 43, 6, 576-580.
47. Jackson RD, LaCroix AZ, Gass M, et al. (2006) Calcium plus Vitamin D Supplementation and the Risk of Fractures. N Engl J Med 354, 7, 669-683. (Pubitemid 43247138)
48. Looker A, Melton L, Borrud L, et al. (2011) Changes in femur neck bone density in US adults between 1988âe"1994 and 2005âe"2008: demographic patterns and possible determinants. Osteoporosis International 1-10.
49. Robbins J, Aragaki AK, Kooperberg C, et al. (2007) Factors Associated With 5-Year Risk of Hip Fracture in Postmenopausal Women. JAMA 298, 20, 2389-2398. (Pubitemid 350190780)
50. Hay AW, Hassam AG, Crawford MA, et al. (1980) Essential fatty acid restriction inhibits vitamin D-dependent calcium absorption. Lipids 15, 4, 251-254. (Pubitemid 10091166)
51. Haag M, Magada ON, Claassen N, et al. (2003) Omega-3 fatty acids modulate ATPases involved in duodenal Ca absorption. Prostaglandins, Leukotrienes and Essential Fatty Acids 68, 6, 423-429. (Pubitemid 36724034)
52. Sun L, Tamaki H, Ishimaru T, et al. (2004) Inhibition of osteoporosis due to restricted food intake by the fish oils DHA and EPA and perilla oil in the rat. Biosci Biotechnol Biochem 68, 12, 2613-2615. (Pubitemid 40218193)
53. Zwart SR, Pierson D, Mehta S, et al. (2010) Capacity of omega-3 fatty acids or eicosapentaenoic acid to counteract weightlessness-induced bone loss by inhibiting NF-kappaB activation: from cells to bed rest to astronauts. J Bone Miner Res 25, 5, 1049-1057.
54. Watkins BA, Li Y & Seifert MF (2001) Nutraceutical fatty acids as biochemical and molecular modulators of skeletal biology. J Am Coll Nutr 20, 5, 410S-416S, discussion 7S-20S. (Pubitemid 32948022)
55. Baggio B, Budakovic A, Nassuato MA, et al. (2000) Plasma phospholipid arachidonic acid content and calcium metabolism in idiopathic calcium nephrolithiasis. Kidney Int 58, 3, 1278-1284.
56. Haag M & Kruger MC (2001) Upregulation of duodenal calcium absorption by poly-unsaturated fatty acids: events at the basolateral membrane. Medical hypotheses 56, 5, 637-640. (Pubitemid 32507032)
57. Leonard F, Haag M & Kruger MC (2001) Modulation of intestinal vitamin D receptor availability and calcium ATPase activity by essential fatty acids. Prostaglandins Leukot Essent Fatty Acids 64, 3, 147-150. (Pubitemid 32896814)